TWiV reviews rhinovirus complications in infants, a new influenza antiviral drug, Oropouche fever in Brazil, measles in Maryland and Ohio, effect of eliminating non-medical vaccine exemptions in NY, foot-and-mouth disease in Europe, severe primary and secondary dengue infections, and therapeutic mitigation of measles-like immune amnesia and exacerbated disease after prior respiratory virus infections.

Hosts: Vincent Racaniello, Dickson Despommier, Rich Condit, and Angela Mingarelli

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

• MicrobeTV Discord Server
• MicrobeTV store at Cafepress
• Become a member of ASV (asv.org)
• Research assistant position in Rosenfeld Lab CBER/FDA (pdf)
• The New City by Dickson Despommier
• Viruses of Microbes 2024
• Infant rhinovirus bronchiolitis contribution to hospital bed and vent use (JAMA Net Open)
• Onradivir new influenza antiviral (Lancet)
• Oropouche fever in Brazil (PAHO)
• Maryland and Ohio measles
• Repealing school vaccination exemptions (JAMA New Open)
• Increases risk of FMDV entry into Europe (pig333)
• Severe primary and secondary dengue (Nat Med)
• Mitigation of measles immune amnesia and exacerbated disease (Nat Comm)
• Letters read on TWiV 1087
• Timestamps by Jolene. Thanks!

Weekly Picks

Dickson – For Your Processing Pleasure: The Sharpest Pictures of Jupiter’s Volcanic Moon Io in a Generation
Angela – Whale Scientists
Rich – Benefit-risk assessment of vaccines; The Brighton collaboration standardized module for vaccine benefit-risk assessment; Vaccine adverse events: causal or coincidental?; Austin area Singing Valentines
Vincent – International Day of Women and Girls in Science, 11 February

Intro music is by Ronald Jenkees

Send your virology questions and comments to [email protected]